Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV8B8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,622
Award facts
- Contract value 100% obligated
- $17,622.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,622.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml syringes, with an ultimate completion date of January 30, 2026. This non-set-aside contract was awarded on January 29, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., functions as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in delivering a comprehensive range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This specific delivery order for Dupixent—a biologic medication used primarily for atopic dermatitis, eosinophilic asthma, and other allergic conditions—exemplifies the company's role in supplying essential pharmaceutical commodities to support Defense Health Agency operations and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FV8B8?
SPE2DR26FV8B8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FV8B8 worth?
The government has obligated $17,622 on SPE2DR26FV8B8.
Is contract SPE2DR26FV8B8 an order under another contract?
Yes. SPE2DR26FV8B8 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV8B8 competed?
The extent of competition for SPE2DR26FV8B8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award